Replies to post #83508 on Biotech Values

[taLuis]

MNTA:

>> "a best-case scenario FDA decision with m-enox in 2009 might give us a the Vanda-like spike."

Is that what you expect from a favorable FDA decision in 2009/2010, a 10-fold spike? Or is that wishful thinking? In other words, what is the upside on PPS to approval versus the downside.

I'm new to MNTA and a novice to biotechs in general and have begun to do my DD on this stock. Your thoughts are appreciated.